Repligen to Report Second Quarter 2024 Financial Results

Company Overview - Repligen Corporation is a global life sciences company focused on developing and commercializing innovative bioprocessing technologies and systems that enhance the manufacturing efficiency of biological drugs [5] - The company serves primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide [5] - Key focus areas include Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [5] - Corporate headquarters are located in Waltham, Massachusetts, with manufacturing sites in the U.S. and additional locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [5] Upcoming Financial Results - Repligen Corporation will report its second quarter 2024 financial results on July 30, 2024 [4] - A press release will be issued before the market opens, followed by a conference call at 8:30 a.m. ET to discuss business updates and financial results for the three- and six-month periods ended June 30, 2024 [4]